Skip to content

Evaluation of New Custom Made Hearing Product Technology and Shell Modification

Evaluation of New Custom Made Hearing Product Technology and Shell Modification

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02545569
Acronym
CPS
Enrollment
25
Registered
2015-09-10
Start date
2020-01-06
Completion date
2020-12-31
Last updated
2019-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Loss, Bilateral or Unilateral

Brief summary

The purpose of this evaluation is to receive the greatest benefit of new custom made hearing product technology and shell modification for the end customer and to continual improve the custom made hearing products.

Detailed description

This is a controlled, single blinded comparative study which is conducted monocentric at Phonak Headquarters in Staefa. The purpose of the studies is to evaluate the strengths and weaknesses of new custom product development in comparison to existing/old products. The results should promote the custom product development, to provide a maximum of benefit and wearing comfort to the hearing aid user.

Interventions

DEVICEhearing aid (MD class IIa) - ITE, BTE, RIC

Hearing aid means any wearable instrument or device designed for, offered for the purpose of, or represented as aiding persons with or compensating for, impaired hearing.

Sponsors

Phonak AG, Switzerland
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* Only adult participants between 18 and 99 years * lnformed Consent as documented by signature (Appendix lnformed Consent Form) * Ability to fill in a questionnaire conscientious * Healthy outer ear (w/o previous surgical procedures)

Exclusion criteria

* Contraindications to the MD in this study, e.g. known hypersensitivity or allergy to the investigational product, * Limited mobility and not in the position to attend weekly appointments * Limited ability to describe listening impressions/experiences and the use of the hearing aid * lnability to produce a reliable hearing test result when pure tone audiometry is attempted by the audiologist * Massively limited dexterity * Psychological problems * Central hearing problems

Design outcomes

Primary

MeasureTime frameDescription
Objective measurement from the position of the outer ear related to the test subject.5 yearsMeasurement in degree.
Objective measurement of speech intelligibility related to the intervention.5 yearsSNR (speech to noise ratio) in decibel.
Objective measurement of the transfer function related to the intervention.5 yearsREM (real ear measurement) in decibel.
Objective measurement of temperature in the ear canal related to the test subject and the intervention.5 yearsMeasurement in degree centigrade.
Objective measurement from the size of the outer ear related to the test subject.5 yearsMeasurement in micron.
Objective measurement of humidity in the ear canal related to the test subject and the intervention.5 yearsMeasurement in percent.

Secondary

MeasureTime frameDescription
Subjective rating of the intervention via questionnaire.5 yearsOrdinal scale

Countries

Switzerland

Contacts

Primary ContactJana-Kosima Schwarzlos, B.Sc.
JanaKosima.Schwarzlos@sonova.com+41 58 928 0101

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026